548 Episodio

  1. Accelerating the Development of Genetic Medicines with AI

    Pubblicato: 07/12/2023
  2. Leveraging AI to Address the Neuropsychiatric Conditions Associated with a Rare Disease

    Pubblicato: 30/11/2023
  3. In Pursuit of a Treatment for His Son, A Lawyer Becomes a Biotech Executive

    Pubblicato: 22/11/2023
  4. In Push for Treatment, a Patient Organization Becomes a Trial Sponsor

    Pubblicato: 16/11/2023
  5. Delayed Diagnosis of Rare Diseases Takes Staggering Economic Toll

    Pubblicato: 09/11/2023
  6. A Cell Therapy to Control Heart-Damaging Inflammation in Duchenne

    Pubblicato: 02/11/2023
  7. Stimulating the Growth of Muscle Mass in People with Neuromuscular Diseases

    Pubblicato: 26/10/2023
  8. Turning Grief into Action

    Pubblicato: 19/10/2023
  9. A Plea to the FDA to Give an Ultra-Rare Disease Drug a Fair Hearing

    Pubblicato: 12/10/2023
  10. How the Woolly Mammoth Beat a Path to Better Gene Therapies

    Pubblicato: 05/10/2023
  11. A Genetic Counselor’s Journey into Patient Advocacy

    Pubblicato: 28/09/2023
  12. A Company in the Fold of Rare Disease

    Pubblicato: 21/09/2023
  13. Disabling Antibodies that Drive Rare, Immunological Conditions

    Pubblicato: 14/09/2023
  14. Keeping the Sentinels of the Brain Vigilant

    Pubblicato: 07/09/2023
  15. Considering the Unfinished Work in Cystic Fibrosis

    Pubblicato: 31/08/2023
  16. How to Advocate for Yourself as You Battle Cancer

    Pubblicato: 24/08/2023
  17. Targeting Neuroinflammation to Treat ALS

    Pubblicato: 17/08/2023
  18. Leveraging Community Partnerships to Address a Rare Disease Behind a Medical Mystery in New Mexico

    Pubblicato: 10/08/2023
  19. Accelerating Gene Editing Therapies for Rare, Neurological Conditions

    Pubblicato: 03/08/2023
  20. Inhibiting Electrical Activity in Rare, Seizure Disorders

    Pubblicato: 27/07/2023

5 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site